Why There Is Limited Support For Anti-Addiction Vaccines Despite The Epidemic Of Opioid Overdoses
In a recent paper published in the journal JAMA Psychiatry, Thomas R. Kosten, from the Department of Psychiatry at Baylor College of Medicine in Houston, Texas, delved into the six factors that have led to very limited support for antiaddiction vaccines.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
More News: Addiction | Baylor College of Medicine | Epidemics | Epidemiology | Overdose | Pharmaceuticals | Psychiatry | Vaccines